Association between sST2 Levels and Cardiovascular Outcomes and Effect of Sacubitril/Valsartan on sST2 Levels: Results From the PARADIGM-HF Trial

被引:3
|
作者
O'Meara, Eileen [1 ]
Prescott, Margaret F. [2 ]
Rouleau, Jean L. [1 ]
Chiang, Lu-May [2 ]
Solomon, Scott D. [3 ]
Swedberg, Karl [4 ]
Packer, Milton [5 ]
McMurray, John J. V. [6 ]
Zile, Michael R. [7 ]
机构
[1] Montreal Heart Inst, Montreal, PQ, Canada
[2] Novartis Pharmaceut, E Hanover, NJ USA
[3] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[4] Univ Gothenburg, Gothenburg, Sweden
[5] Baylor Univ, Med Ctr, Dallas, TX USA
[6] Univ Glasgow, Glasgow, Lanark, Scotland
[7] Med Univ South Carolina, Charleston, SC USA
关键词
D O I
10.1016/j.cardfail.2016.06.094
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
077
引用
收藏
页码:S29 / S30
页数:2
相关论文
共 50 条
  • [41] Serum Levels of Hcy, sST2 and CA-125 in CHF Patients and Their Correlation with Cardiac Function Classification
    Ma, Wuzhi
    Zhang, Peng
    Hu, Huiqiong
    HEART SURGERY FORUM, 2023, 26 (05): : E449 - E454
  • [42] sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trial
    David M. Smadja
    Clément R. Massonnaud
    Aurélien Philippe
    Mickael Rosa
    Sophie Luneau
    Antoine Rauch
    Nathan Peiffer-Smadja
    Amandine Gagneux-Brunon
    Julien Poissy
    Maxime Gruest
    Alexandre Ung
    Valérie Pourcher
    François Raffi
    Lionel Piroth
    Kévin Bouiller
    Hélène Esperou
    Christelle Delmas
    Drifa Belhadi
    Alpha Diallo
    Juliette Saillard
    Aline Dechanet
    Noémie Mercier
    Axelle Dupont
    François-Xavier Lescure
    François Goehringer
    Stéphane Jaureguiberry
    François Danion
    Violaine Tolsma
    André Cabie
    Johan Courjon
    Sylvie Leroy
    Joy Mootien
    Bruno Mourvillier
    Sébastien Gallien
    Jean-Philippe Lanoix
    Elisabeth Botelho-nevers
    Florent Wallet
    Jean-Christophe Richard
    Jean Reuter
    Alexandre Gaymard
    Richard Greil
    Guillaume Martin-Blondel
    Claire Andrejak
    Yazdan Yazdanpanah
    Charles Burdet
    Jean-Luc Diehl
    Maya Hites
    Florence Ader
    Sophie Susen
    France Mentré
    Scientific Reports, 15 (1)
  • [43] Long-term prognostic importance of high levels of sST2 in patient with AMI: a meta-analysis
    Ji, Haigang
    Yuan, Ling
    Jiang, Wenbo
    Chen, Jing
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (01): : 1 - +
  • [44] Prediction of myocardial ischemia–reperfusion injury post-PCI: role of sST2 levels in STEMI patients
    Wenjing Che
    Yubin Jin
    Shumin Chang
    Yihan Sun
    Aijie Hou
    Chengfu Wang
    BMC Cardiovascular Disorders, 25 (1)
  • [45] Sacubitril/Valsartan Reduces Serum Uric Acid Level, an Independent Predictor of Adverse Outcomes in HFrEF: Results From PARADIGM-HF
    Mogensen, Ulrik M.
    Jhund, Pardeep S.
    Kober, Lars
    Prescott, Margaret F.
    Lefkowitz, Martin P.
    Rouleau, Jean-Lucien
    Solomon, Scott D.
    Swedberg, Karl
    Zile, Michael R.
    Packer, Milton
    McMurray, John J. V.
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (08) : S15 - S15
  • [46] Salivary IL-33 and sST2 levels in relation to TLR2 rs111200466 polymorphism and periodontitis
    Yilmaz, Mustafa
    He, Qiushui
    Demir, Esra
    Terasjarvi, Johanna
    Gursoy, Ulvi Kahraman
    ORAL DISEASES, 2024, 30 (04) : 2254 - 2261
  • [47] Evaluation of interleukin-33 & sST2 levels in type-2 diabetic mellitus patients with or without metabolic syndrome
    Singh, Himadri
    Khadanga, Sagar
    Goel, Sudhir K.
    Majumder, Syamantak
    Baig, Mirza S.
    Bhatia, Vikas
    Chaudhary, Neha
    Saluja, Rohit
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2023, 157 (05) : 470 - 476
  • [48] Relationship between sST2 and NT-proBNP levels and postoperative atrial fibrillation in patients having non-cardiac surgery
    Somuncu, Mustafa U.
    Gudul, Naile E.
    Kokturk, Ugur
    Koksal, Bengu G.
    Tatar, Fatih P.
    Avci, Ahmet
    MINERVA CARDIOLOGY AND ANGIOLOGY, 2024,
  • [49] SOLUBLE SUPPRESSION OF TUMORIGENICITY 2 (SST2) AND CARDIOVASCULAR OUTCOMES IN PERSONS WITH TYPE 2 DIABETES MELLITUS RANDOMIZED TO DAPAGLIFLOZIN OR PLACEBO: ANALYSES FROM THE DECLARE-TIMI 58 TRIAL
    Haller, Paul
    Wiviott, Stephen
    Jarolim, Petr
    Goodrich, Erica L.
    Bhatt, Deepak L.
    Gause-Nilsson, Ingrid
    Leiter, Lawrence A.
    McGuire, Darren K.
    Raz, Itamar
    Wilding, John
    Sabatine, Marc Steven
    Morrow, David A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 378 - 378
  • [50] Use of an inducible expression system to examine the effects of altering human sst2(A) receptor expression levels on receptor activation
    Cole, SL
    Schindler, M
    Humphrey, PPA
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 : U50 - U50